Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis

Elevated VTE rates have been reported in COVID-19 patients [1,2]. Although ICU patients in general have an elevated VTE risk [3] we recently reported a higher incidence of VTE in ICU compared to ward patients with COVID-19 [4]. As the optimal approach for thromboprophylaxis is unknown, we implemented intermediate dose anticoagulation in COVID-19 ICU patients. We hypothesized that intermediate dose heparin prophylaxis would be associated with...